Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperthermia and CCRT in Treatment Failure Solid Tumors
NCT02120118Phase 2Withdrawn
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Start
- Feb 2014
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Shin Kong Wu Ho-Su Memorial Hospital. Primary endpoint: Tumor response rate at 12 weeks. Planned start Feb 2014; status: withdrawn.
Beyond the preview
Go deeper on NCT02120118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120118.